Medical Laboratories Industry - SEC Form 4 Insider Trading Screener

Services Sector - Health Services - Medical Laboratories
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-02-12
GHDXGenomic Health IncCole G BradleyCFOS - Sale+OE$80.87-15,00048,067-24%-$1,213,024
D
2019-02-12
LHLaboratory Corp of America HoldingsBelingard Jean-LucDirS - Sale+OE$146.06-3,70034,013-10%-$540,407
D
2019-02-13
LHLaboratory Corp of America HoldingsWilliams R SandersDirS - Sale+OE$147.00-1,0387,886-12%-$152,586
D
2019-02-12
CDNACaredx, Inc.Yee James PChief Medical OfficerS - Sale+OE$23.88-32,50044,692-42%-$776,100
D
2019-02-11
VCYTVeracyte, Inc.Anderson Bonnie HCOB, CEOS - Sale+OE$18.17-8,000175,626-4%-$145,364
D
2019-02-07
GHDXGenomic Health IncVaughn James JChief Commercial OfficerS - Sale+OE$77.42-3,00024,125-11%-$232,272
DM
2019-02-01
GHDXGenomic Health IncShak StevenChief Scientific OfficerS - Sale+OE$76.29-50,000339,671-13%-$3,814,693
DM
2019-01-30
GHDXGenomic Health IncShak StevenChief Scientific OfficerS - Sale+OE$74.24-50,000339,671-13%-$3,711,800
2019-01-31
CGIXCancer Genetics, IncRoberts John ACEOP - Purchase$0.23+185,436297,636+165%+$42,650
2019-01-31
CGIXCancer Genetics, IncMiles Michael GlennCFOP - Purchase$0.23+150,000150,000New+$34,500
2019-01-31
CGIXCancer Genetics, IncCannon EdmundDirP - Purchase$0.23+43,47961,873+236%+$10,000
2019-01-31
CGIXCancer Genetics, IncPappajohn JohnDirP - Purchase$0.23+1,000,0004,781,204+26%+$230,000
2019-01-28
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$71.07-46,4779,266,4620%-$3,302,980
M
2019-01-23
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$71.86-208,8319,304,756-2%-$15,006,328
2019-01-22
GHDXGenomic Health IncRadford Jason W.GCS - Sale$71.44-2,96331,326-9%-$211,683
2019-01-22
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$71.00-51,6069,476,826-1%-$3,664,031
M
2019-01-17
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$71.75-371,6899,519,347-4%-$26,667,110
2019-01-16
NVTAInvitae CorpDumond PattySee RemarksS - Sale$15.00-3,00093,811-3%-$45,000
2019-01-16
NVTAInvitae CorpGuyer Shelly DCFOS - Sale$14.49-4,000160,865-2%-$57,968
2019-01-14
CGIXCancer Genetics, IncHarris Geoffrey E.DirP - Purchase$0.23+100,000127,500+364%+$22,500
2019-01-14
CGIXCancer Genetics, IncPappajohn JohnDirP - Purchase$0.23+1,000,0003,781,204+36%+$225,000
2019-01-14
CGIXCancer Genetics, IncRoberts John ACEOP - Purchase$0.23+100,000112,200+820%+$22,500
2019-01-15
NVTAInvitae CorpStueland KatherineChief Commercial OfficerS - Sale$13.59-1,000188,370-1%-$13,590
2019-01-10
NVTAInvitae CorpNussbaum Robert LChief Medical OfficerS - Sale$14.01-5,222163,769-3%-$73,153
A
2018-11-12
NVTAInvitae CorpNussbaum Robert LChief Medical OfficerS - Sale$13.11-10,444168,991-6%-$136,964
M
2019-01-10
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$70.23-39,2599,825,6060%-$2,757,356
DM
2019-01-09
VCYTVeracyte, Inc.Anderson Bonnie HCOB, CEOS - Sale+OE$15.29-25,500175,626-13%-$389,897
D
2019-01-08
GHDXGenomic Health IncCole G BradleyCFOS - Sale+OE$67.03-15,00044,047-25%-$1,005,401
D
2019-01-08
GHDXGenomic Health IncVaughn James JChief Commercial OfficerS - Sale+OE$67.06-3,00017,763-14%-$201,181
D
2018-12-24
NTRANatera, Inc.Chapman Steven LeonardCOOS - Sale+OE$12.39-5651,114-34%-$7,001
D
2018-12-24
NTRANatera, Inc.Sheena JonathanCTOS - Sale+OE$12.39-507231,0350%-$6,282
D
2018-12-24
NTRANatera, Inc.Brophy Michael BurkesCFOS - Sale+OE$12.39-4491,339-25%-$5,563
2018-12-20
RDNTRadnet, Inc.Hames Norman RPres, Western OperationsS - Sale$10.40-15,000544,000-3%-$156,000
2018-12-19
RDNTRadnet, Inc.Hames Norman RPres, Western OperationsS - Sale$10.78-10,000559,000-2%-$107,800
2018-12-17
NVTAInvitae CorpStueland KatherineChief Commercial OfficerS - Sale$11.44-1,000189,370-1%-$11,437
M
2018-12-17
GHDXGenomic Health IncPopovits Kimberly JPres, CEOS - Sale$66.79-50,000186,348-21%-$3,339,527
2018-12-13
RDNTRadnet, Inc.Hames Norman RPres, Western OperationsS - Sale$12.68-5,000569,000-1%-$63,400
2018-12-10
RDNTRadnet, Inc.Hames Norman RPres, Western OperationsS - Sale$12.57-15,000574,000-3%-$188,550
D
2018-12-11
GHDXGenomic Health IncCole G BradleyCFOS - Sale+OE$71.95-15,00044,047-25%-$1,079,219
M
2018-12-10
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$73.83-85,4209,857,643-1%-$6,306,394
D
2018-12-10
VCYTVeracyte, Inc.Anderson Bonnie HCOB, CEOS - Sale+OE$12.13-8,000175,626-4%-$97,077
M
2018-12-06
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$75.82-195,1349,928,025-2%-$14,795,980
2018-12-04
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$75.62-32,77610,088,8070%-$2,478,447
D
2018-12-06
GHDXGenomic Health IncVaughn James JChief Commercial OfficerS - Sale+OE$75.30-3,00017,763-14%-$225,888
D
2018-12-03
GHDXGenomic Health IncShak StevenChief Scientific OfficerS - Sale+OE$78.18-1,500336,7410%-$117,273
2018-12-03
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$78.49-202,13410,115,813-2%-$15,865,833
M
2018-11-29
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$78.95-256,03510,282,364-2%-$20,214,213
M
2018-11-28
CDNACaredx, Inc.Maag PeterSee RemarksS - Sale$28.53-100,000402,541-20%-$2,852,512
2018-11-27
LHLaboratory Corp of America HoldingsWilliams R SandersDirS - Sale$162.14-3507,886-4%-$56,749
2018-11-27
NVTAInvitae CorpAguiar EricDirS - Sale$13.50-10,0000-100%-$135,000
2018-11-28
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$75.61-250,39210,493,327-2%-$18,932,283
M
2018-11-26
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$74.13-178,28510,699,641-2%-$13,216,202
2018-11-16
NVTAInvitae CorpDumond PattySee RemarksS - Sale$12.90-2,00096,811-2%-$25,800
2018-11-16
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$76.65-87,39510,846,542-1%-$6,699,000
2018-11-16
GHDXGenomic Health IncPopovits Kimberly JPres, CEOS - Sale$76.72-10,000236,937-4%-$767,171
DM
2018-11-15
GHDXGenomic Health IncPopovits Kimberly JPres, CEOS - Sale+OE$77.01-40,000248,797-14%-$3,080,354
2018-11-13
CDNACaredx, Inc.Maag PeterSee RemarksS - Sale$26.48-50,000391,747-11%-$1,323,945
2018-11-13
FLGTFulgent Genetics, Inc.Hsieh MingPres, CEO, 10%P - Purchase$3.59+10,8807,886,3760%+$39,032
D
2018-11-13
GHDXGenomic Health IncCole G BradleyCFOS - Sale+OE$79.18-8,57645,372-16%-$679,027
D
2018-11-09
GHDXGenomic Health IncShak StevenChief Scientific OfficerS - Sale+OE$83.21-5,500336,741-2%-$457,646
2018-11-13
FLGTFulgent Genetics, Inc.Kim PaulCFO, TreasurerS - Sale$3.50-1,446381,1800%-$5,062
2018-11-13
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$79.69-114,85810,918,553-1%-$9,153,059
M
2018-11-12
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$79.33-204,30011,013,192-2%-$16,206,624
M
2018-11-09
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$82.34-183,75911,181,530-2%-$15,130,925
2018-11-09
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$83.71-107,73811,332,941-1%-$9,018,337
D
2018-11-08
GHDXGenomic Health IncVaughn James JChief Commercial OfficerS - Sale+OE$85.18-3,00017,542-15%-$255,545
D
2018-11-08
GHDXGenomic Health IncCohen Fred EDirS - Sale+OE$87.93-10,00073,532-12%-$879,262
2018-11-08
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$86.50-76,27311,421,712-1%-$6,597,504
2018-11-08
GHDXGenomic Health IncBaker Bros. Advisors LPDir, 10%S - Sale$85.58-72,74511,484,556-1%-$6,225,158
D
2018-11-12
VCYTVeracyte, Inc.Anderson Bonnie HCOB, CEOS - Sale+OE$13.42-23,305151,626-13%-$312,786
2018-11-09
FLGTFulgent Genetics, Inc.Hsieh MingPres, CEO, 10%P - Purchase$3.36+10,0007,875,4960%+$33,610
D
2018-11-07
GHDXGenomic Health IncPla FredericCOOS - Sale+OE$84.91-43,50035,538-55%-$3,693,589
D
2018-11-05
LHLaboratory Corp of America HoldingsAnderson Kerrii BDirS - Sale+OE$163.29-3,70018,095-17%-$604,162
2018-10-31
CDNACaredx, Inc.Gagnon Neil10%S - Sale$27.05-108,5992,048,465-5%-$2,937,331
D
2018-10-31
VCYTVeracyte, Inc.Hall Christopher MPres, COOS - Sale+OE$13.51-40,00032,455-55%-$540,271
2018-10-29
ENZEnzo Biochem IncRabbani ElazarChm of the Bd, CEO, SecP - Purchase$3.35+10,0001,848,668+1%+$33,469
2018-10-25
ANIXAnixa Biosciences IncTitterton Lewis H JrDirP - Purchase$4.05+2,000841,5440%+$8,100
2018-10-25
ANIXAnixa Biosciences IncKumar AmitCEOP - Purchase$3.90+11,000150,000+8%+$42,900
2018-10-18
ENZEnzo Biochem IncPerlysky DovDirP - Purchase$3.50+10,000789,692+1%+$35,000
2018-10-18
ENZEnzo Biochem IncHanna Bruce A.DirP - Purchase$3.52+15,00037,816+66%+$52,787
DM
2018-10-15
NTRANatera, Inc.Sheena JonathanCTOS - Sale+OE$20.66-166,667515,054-24%-$3,443,980
DM
2018-10-15
GHDXGenomic Health IncPopovits Kimberly JPres, CEOS - Sale+OE$65.28-50,000248,797-17%-$3,264,166
D
2018-10-12
NTRANatera, Inc.Chapman Steven LeonardCOOS - Sale+OE$20.66-35,000562-98%-$723,195
2018-10-11
MGENMiragen Therapeutics, Inc.Hughes Thomas E.DirP - Purchase$4.77+10,00012,827+354%+$47,697
D
2018-10-09
GHDXGenomic Health IncShak StevenChief Scientific OfficerS - Sale+OE$64.35-5,500336,741-2%-$353,950
D
2018-10-10
GHDXGenomic Health IncCole G BradleyCFOS - Sale+OE$63.19-5,00045,372-10%-$315,955
D
2018-10-08
GHDXGenomic Health IncPla FredericCOOS - Sale+OE$65.43-1,50035,538-4%-$98,148
DM
2018-10-08
GHDXGenomic Health IncVaughn James JChief Commercial OfficerS - Sale+OE$64.86-50,00017,542-74%-$3,242,843
2018-10-05
CDNACaredx, Inc.King SashaChief Commercial OfficerS - Sale$24.60-11,50053,542-18%-$282,900
D
2018-10-02
NTRANatera, Inc.Chapman Steven LeonardCOOS - Sale+OE$23.76-35,000562-98%-$831,611
2018-09-27
NTRANatera, Inc.Rabinowitz MatthewCEOS - Sale$22.84-81,099612,344-12%-$1,852,499
D
2018-09-26
NTRANatera, Inc.Chapman Steven LeonardCOOS - Sale+OE$24.88-9,200562-94%-$228,870
M
2018-09-24
NTRANatera, Inc.Rabinowitz MatthewCEOS - Sale$24.85-324,844693,443-32%-$8,071,471
D
2018-09-24
NTRANatera, Inc.Chapman Steven LeonardCOOS - Sale+OE$23.78-5623,762-13%-$13,364
D
2018-09-24
NTRANatera, Inc.Brophy Michael BurkesCFOS - Sale+OE$23.78-446671-40%-$10,606
D
2018-09-24
NTRANatera, Inc.Sheena JonathanCTOS - Sale+OE$23.78-324347,0920%-$7,704
2018-09-20
RDNTRadnet, Inc.Hames Norman RPres, Western OperationsS - Sale$15.59-14,000589,000-2%-$218,260
M
2018-09-19
NTRANatera, Inc.Rabinowitz MatthewCEOS - Sale$23.88-212,0011,018,287-17%-$5,063,617
D
2018-09-19
NTRANatera, Inc.Chapman Steven LeonardCOOS - Sale+OE$23.81-35,0003,207-92%-$833,177
M
2018-09-18
NVTAInvitae CorpDumond PattySee RemarksS - Sale$16.58-64598,811-1%-$10,695
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top